155 related articles for article (PubMed ID: 31562674)
21. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
22. [Multimodal imaging of breast cancer recurrence : Prospective intraindividual comparison of
Avanesov M; Derlin T
Radiologe; 2017 Jan; 57(1):1-3. PubMed ID: 27757490
[No Abstract] [Full Text] [Related]
23. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
24. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
25. 18F-FDG-avid brunner gland hyperplasia.
Park SH; Park KM; Kim JS
Clin Nucl Med; 2014 Aug; 39(8):728-30. PubMed ID: 24686216
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET/CT unilateral breast enlargement and diffuse hypermetabolism related to unilateral lactation in a patient with primary biliary cirrhosis.
Ngaserin S; Chua HW; Mipuri TM
Breast J; 2020 Oct; 26(10):2094-2095. PubMed ID: 32469088
[No Abstract] [Full Text] [Related]
27. FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer.
Groheux D
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1417-1419. PubMed ID: 28573331
[No Abstract] [Full Text] [Related]
28. Correlation Between
Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
30. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
Melsaether AN; Raad RA; Pujara AC; Ponzo FD; Pysarenko KM; Jhaveri K; Babb JS; Sigmund EE; Kim SG; Moy LA
Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
[TBL] [Abstract][Full Text] [Related]
32.
Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.
Dong A; Wang Y; Lu J; Zuo C
Clin Nucl Med; 2016 Jul; 41(7):543-57. PubMed ID: 26975010
[TBL] [Abstract][Full Text] [Related]
34. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Li P; Liu Q; Wang X; Huang G; Song S
Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557
[TBL] [Abstract][Full Text] [Related]
35. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
[TBL] [Abstract][Full Text] [Related]
36. Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
Hu YY; Zhang X; Long W; Lin XP; Zhang YR; Li YH; Xiao ZZ; Zheng RL; Liang PY; Fan W
Eur J Radiol; 2015 Jul; 84(7):1378-82. PubMed ID: 25882963
[TBL] [Abstract][Full Text] [Related]
37. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
Nishimatsu K; Nakamoto Y; Miyake KK; Ishimori T; Kanao S; Toi M; Togashi K
Eur J Radiol; 2017 May; 90():138-145. PubMed ID: 28583624
[TBL] [Abstract][Full Text] [Related]
38. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
Satoh Y; Motosugi U; Imai M; Onishi H
Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET/CT Findings in a Patient With Primary Mucinous Cystadenocarcinoma of the Breast.
Hu Y; Tian C; Zhang X; Wei Q; Bian Y
Clin Nucl Med; 2020 Feb; 45(2):159-160. PubMed ID: 31876834
[TBL] [Abstract][Full Text] [Related]
40. The accuracy of
Tian F; Shen G; Deng Y; Diao W; Jia Z
Eur Radiol; 2017 Nov; 27(11):4786-4796. PubMed ID: 28477166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
